Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations

Abstract Objective Despite the remarkable improvements in pharmacologic treatment efficacy for hepatitis C (HCV) reported in published clinical trials, published research suggests that, in “real-world” patient care, these medical outcomes may be difficult to achieve. This review was undertaken to su...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	General hospital psychiatry 2013-03, Vol.35 (2), p.122-128
Hauptverfasser:	North, Carol S., M.D., M.P.E, Hong, Barry A., Ph.D, Adewuyi, Sunday A., M.B.B.S, Pollio, David E., Ph.D, Jain, Mamta K., M.D., M.P.H, Devereaux, Robert, Ph.D, Quartey, Nana A., M.D, Ashitey, Sarah, M.D, Lee, William M., M.D, Lisker-Melman, Mauricio, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Biomedical Research Clinical Trials as Topic Coinfection - drug therapy Course of treatment HCV/HIV coinfection Hepacivirus - drug effects Hepatitis C Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology HIV Infections - drug therapy Humans Institution therapy. Inpatient treatment Medical sciences Pharmacology. Drug treatments Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychosocial barriers to treatment Sustained virologic response Treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!